Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Electrochem Announces Patent Award For Battery Support System

November 20, 2012 9:00 am | by The Associated Press | News | Comments

CLARENCE, N.Y.--(BUSINESS WIRE)--Nov 20, 2012--Electrochem Solutions, Inc. (Electrochem), a subsidiary of Greatbatch, Inc. (NYSE:GB) today announced an award for U.S. Patent No. 8,252,441 - Spacers for Fixing Battery Cells Within a Battery Package Casing and Associated Systems and Methods (File...

Stryker exec charged in $1.7M insider trading scheme | MassDevice.com On Call

November 20, 2012 8:29 am | by Mass Device | News | Comments

The Securities & Exchange Commission charges Stryker marketing executive Mark Foldy alongside a handful of others in an insider trading scheme that allegedly generated $1.7 million in illegal profits and kickbacks. MASSDEVICE ON CALL — Former Stryker (NYSE:SYK) marketing executive Mark Foldy was charged alongside a handful of others for his alleged participation in an insider trading scheme that federal authorities say generated $1.7 million in illegal profits and kickbacks. Legal News, News Well, Insider Trading, On Callread more

Medtronic Reports Second Quarter Earnings

November 20, 2012 7:18 am | by The Associated Press | News | Comments

Revenue of $4.1 Billion Grew 5% on a Constant Currency Basis; 2% as Reported International Revenue Grew 8% on a Constant Currency Basis; 1% as Reported Company Updates FY13...

Advertisement

Victims of meningitis outbreak file petition in Mass. court

November 20, 2012 12:00 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Several law firms, including Brown Rudnick LLP and Andrews & Thorton, have filed a petition in Massachusetts state court to appoint a receiver in the case against New England Compounding Center, the Framingham pharmacy at the center of the deadly fungal meningitis outbreak.

Thermo Fisher licenses sepsis test to Japanese firm

November 20, 2012 12:00 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Thermo Fisher Scientific Inc.(NYSE: TMO) has signed a long-term license agreement with Japanese firm Fujirebio Inc. to make its test for the early detection of sepsis available on the Japanese firms laboratory instruments.

Pot-dispensing machine maker explains stock highs

November 20, 2012 12:00 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Medbox Inc. (OTC:MDBX), a California-based company with offices in Connecticut, which has developed a drug dispensing system that uses hardware, software and biometric scans to verify a medical marijuana patient’s identity has using both the person’s ID card and a biometric fingerprint scan, has seen its stock jump to record highs recently.

medInt and Nuance Offers Integrated Workflow Solution to be showcased at the Nuance Partner Pavilion at RSNA 2012

November 19, 2012 7:07 pm | by The Associated Press | News | Comments

medInt Holdings, LLC, a Healthcare IT company offering enterprise-wide imaging solutions, and Nuance Communications, Inc. today announced the integration of their respective technologies to provide radiation dose information to radiologists. The collaboration between these organizations comes...

NuVasive Management to Participate in Investor Events in November and December 2012

November 19, 2012 4:30 pm | by The Associated Press | News | Comments

NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that management will participate in the following investor events in November and December 2012: ...

Advertisement

Medtronic’s Endurant AAA Stent Graft Delivers Durable Outcomes for Abdominal Aortic Aneursym Repair

November 19, 2012 3:13 pm | by Medtronic | News | Comments

Chosen for nearly one out of every two endovascular abdominal aortic aneurysm repairs worldwide, the Endurant AAA stent graft system from Medtronic, Inc. continues to show robust results in mid-term follow-up, according to two-year clinical data presented at VEITHsymposium, which concluded yesterday in New York.

TOPICS:

Medical device tax: Are "lame duck" lobbying efforts in vain?

November 19, 2012 1:52 pm | by Mass Device | News | Comments

Medical device industry players have focused their latest repeal efforts on pushing Congress during the "lame duck" session after the election, but some are skeptical that the tax will be addressed before it hits next year. Medical device industry stakeholders have spent much time and money lobbying to repeal the 2.3% medical device tax before it takes effect in January, but voices from Capitol Hill are starting to temper that enthusiasm. Rep. Bill Owens (D-N.Y.), who was one of a dozen Democrats to sign on to a House bill to repeal the medtech levy earlier this year, told reporters last week that medical device makers may have better luck repealing the tax in 2013. News Well, Capitol Hill, Medical Device Taxread more

KCI in stealthy buyout of MoMelan | Wall Street Beat

November 19, 2012 1:16 pm | by Mass Device | News | Comments

Skin graft company MoMelan is acquired in a stealthy buyout by Kinetic Concepts Inc., Xconomy reports. Kinetic Concepts executed an under-the-radar buyout of skin graft developer MoMelan Technologies, according to Xconomy.com, citing an anonymous investor in MoMelan. The acquisition, to which the investor declined to assign a value, is "a good outcome for everybody – founders, investors, employees," according to the unnamed source. News Well, Mergers & Acquisitions, Wall Street Beat, Wound Therapyread more

Medtronic's Endurant AAA Stent Graft Delivers Durable Outcomes for Abdominal Aortic Aneursym Repair

November 19, 2012 1:06 pm | by The Associated Press | News | Comments

Two-Year Clinical Data Presented at VEITHsymposium Demonstrate Consistently Strong Performance Worldwide in Pre- and Post-Market Evaluations of Innovative Medical Device MINNEAPOLIS -- Nov. 19, 2012 -- Chosen for nearly one out of every...

Dune Medical lands conditional approval for MarginProbe breast cancer screening tool

November 19, 2012 12:59 pm | by Mass Device | News | Comments

The FDA awards Dune Medical Devices' MarginProbe breast cancer detection system an "approvable letter," with full approval pending final agreement on post-approval study design. Framingham, Mass.-based Dune Medical Devices inched closer to premarket approval from the FDA for its MarginProbe breast cancer detection tool, winning an "approvable letter" from the federal watchdog agency. The company is working together with the FDA on the design of the required post approval study for the MarginProbe system, the final step before Dune can commercialize the product in the U.S., according to the approvable letters. News Well, Breast Cancer, Food & Drug Administration (FDA), Pre-Market Approval (PMA), Women's Healthread more

Sanovas Inc. Receives Patent Allowance for Nested Balloon Catheter for Localized Drug Delivery

November 19, 2012 12:27 pm | by Sanovas | News | Comments

Sanovas Inc., a life science technology company focused on developing and commercializing the next-generation of micro-invasive diagnostics, devices and drug delivery technologies, announced today that the United States Patent and Trademark Office has issued a Notice of Allowance for the company’s nested balloon catheter for localized drug delivery, a component of Sanovas’ Vas Zeppelin Smart Catheter technology portfolio.

TOPICS:

Dr. TATTOFF Announces Use of Astanza Laser Tattoo Removal Systems for New Phoenix Location

November 19, 2012 12:17 pm | by Bio-Medicine.Org | News | Comments

PHOENIX, Nov. 19, 2012 /- The world's leading chain of laser tattoo removal clinics, Dr. TATTOFF, has partnered with Astanza Laser, a leading manufacturer of q-switched lasers specifically designed for tattoo removal. Q-switched lasers, such as the Astanza system in the Phoenix clinic, are widely recognized as the gold standard for effective treatment for unwanted tattoos. Use of ta...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading